Published in J Addict Med on March 01, 2011
A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry (2013) 2.29
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). J Stud Alcohol Drugs (2013) 1.22
The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol (2015) 1.08
Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine (2012) 1.03
Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence. Am J Addict (2013) 0.92
Improving public health through access to and utilization of medication assisted treatment. Int J Environ Res Public Health (2011) 0.90
Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials Network. Subst Abuse Rehabil (2011) 0.90
Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. Drug Alcohol Depend (2011) 0.90
Engagement, retention, and abstinence for three types of opioid users in Florida. Subst Use Misuse (2013) 0.87
Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend (2016) 0.87
Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug Alcohol Depend (2014) 0.86
Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens. J Med Chem (2013) 0.86
Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse (2013) 0.85
Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity. Am J Drug Alcohol Abuse (2014) 0.85
Comparing the life concerns of prescription opioid and heroin users. J Subst Abuse Treat (2014) 0.83
Prescription drug abuse: from epidemiology to public policy. J Subst Abuse Treat (2014) 0.83
Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profiles. Subst Abuse Treat Prev Policy (2014) 0.82
Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence. Am J Psychiatry (2011) 0.80
Advances in opioid antagonist treatment for opioid addiction. Psychiatr Clin North Am (2012) 0.80
Treatment of prescription opioid disorders in Canada: looking at the 'other epidemic'? Subst Abuse Treat Prev Policy (2016) 0.80
Prescription opioid misuse and mental health among young injection drug users. Am J Drug Alcohol Abuse (2014) 0.79
Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers. Addict Behav (2014) 0.78
Spontaneous reductions in smoking during double-blind buprenorphine detoxification. Addict Behav (2014) 0.78
Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program. J Psychoactive Drugs (2015) 0.78
Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria. Trials (2015) 0.77
Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization. J Subst Abuse Treat (2016) 0.75
Correlates of Opioid Use in Adults With Self-Reported Drug Use Recruited From Public Safety-Net Primary Care Clinics. J Addict Med (2015) 0.75
Opioid Use Disorders. Child Adolesc Psychiatr Clin N Am (2016) 0.75
Comparisons of Cocaine-Only, Opioid-Only, and Users of Both Substances in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Subst Use Misuse (2016) 0.75
Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems? Subst Abuse Treat Prev Policy (2016) 0.75
Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. J Subst Abuse Treat (2016) 0.75
Past year non-medical opioid use and abuse and PTSD diagnosis: Interactions with sex and associations with symptom clusters. Addict Behav (2016) 0.75
Disruptive office behaviors in the medical setting: associations with other clinical phenomena. Innov Clin Neurosci (2013) 0.75
Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China. Drug Alcohol Depend (2014) 0.75
Factors associated with naloxone administration in an opioid dependent sample. J Subst Abuse Treat (2017) 0.75
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2004) 15.99
The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend (2003) 12.78
Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf (2006) 8.65
The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry (1998) 8.38
College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend (2003) 6.80
Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry (1998) 4.69
Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend (2007) 3.44
Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend (2004) 2.82
Characterizing the emerging population of prescription opioid abusers. Am J Addict (2006) 2.42
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med (2007) 2.38
National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician (2007) 2.30
Gender and non-medical use of prescription opioids: results from a national US survey. Addiction (2007) 2.15
Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction (2009) 1.88
Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain (2008) 1.75
Sources of prescriptions for misuse by adolescents: differences in sex, ethnicity, and severity of misuse in a population-based study. J Am Acad Child Adolesc Psychiatry (2009) 1.18
Substance use disorders among inhalant users: results from the National Epidemiologic Survey on alcohol and related conditions. Addict Behav (2008) 1.04
Illicit opioid use in the 21st century: witnessing a paradigm shift? Addiction (2007) 0.97
The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions. Am J Addict (2009) 0.94
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend (2005) 4.65
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
MET meets the real world: design issues and clinical strategies in the Clinical Trials Network. J Subst Abuse Treat (2002) 2.08
Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry (2007) 2.07
The availability of web sites offering to sell opioid medications without prescriptions. Am J Psychiatry (2006) 1.93
Depressive symptoms in middle age and the development of later-life functional limitations: the long-term effect of depressive symptoms. J Am Geriatr Soc (2010) 1.88
Depressive symptoms and indicators of maternal health status during pregnancy. J Womens Health (Larchmt) (2007) 1.86
Abuse of buprenorphine in the United States: 2003-2005. J Addict Dis (2007) 1.82
Racial/ethnic variations in substance-related disorders among adolescents in the United States. Arch Gen Psychiatry (2011) 1.80
Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr (2010) 1.79
Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients. Biol Psychiatry (2005) 1.77
The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med (2007) 1.70
Genetic testing for Alzheimer's and long-term care insurance. Health Aff (Millwood) (2010) 1.67
The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol (2012) 1.66
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat (2006) 1.63
Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients. Ann Surg (2015) 1.55
Buprenorphine use: the international experience. Clin Infect Dis (2006) 1.55
Identifying a national death index match. Am J Epidemiol (2009) 1.48
Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery (2007) 1.47
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Body mass index and depressive symptoms in older adults: the moderating roles of race, sex, and socioeconomic status. Am J Geriatr Psychiatry (2007) 1.39
Protection from late life depression. Int Psychogeriatr (2009) 1.38
Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat (2004) 1.35
Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry (2007) 1.31
An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27
Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend (2010) 1.27
Epidemiology of late-life mental disorders. Clin Geriatr Med (2003) 1.26
Successful aging. Am J Geriatr Psychiatry (2006) 1.25
Racial differences in cognitive decline in a sample of community-dwelling older adults: the mediating role of education and literacy. Am J Geriatr Psychiatry (2005) 1.23
Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment. Addict Sci Clin Pract (2012) 1.23
Application of assessing care of vulnerable elders-3 quality indicators to patients with advanced dementia and poor prognosis. J Am Geriatr Soc (2007) 1.22
Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22
Illicit and nonmedical drug use among older adults: a review. J Aging Health (2010) 1.22
Profiles of depressive symptoms in older adults diagnosed with major depression: latent cluster analysis. Am J Geriatr Psychiatry (2009) 1.21
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Factors contributing to dropping out from and returning to HIV treatment in an inner city primary care HIV clinic in the United States. AIDS Care (2013) 1.18
Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Arch Gen Psychiatry (2012) 1.18
Aversive parenting in China: associations with child physical and relational aggression. Child Dev (2006) 1.17
Racial disparities in elevated prenatal depressive symptoms among black and white women in eastern north Carolina. Ann Epidemiol (2005) 1.16
Maternal prenatal pregnancy-related anxiety and spontaneous preterm birth in Baltimore, Maryland. Psychosom Med (2007) 1.15
Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend (2003) 1.15
The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13
A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage (2006) 1.13
The influence of depression on cognitive decline in community-dwelling elderly persons. Am J Geriatr Psychiatry (2005) 1.11
Alcohol and drug use disorders among adults in emergency department settings in the United States. Ann Emerg Med (2012) 1.11
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry (2011) 1.10
Twenty-year depressive trajectories among older women. Arch Gen Psychiatry (2012) 1.09
Construct and differential item functioning in the assessment of prescription opioid use disorders among American adolescents. J Am Acad Child Adolesc Psychiatry (2009) 1.05
Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry (2011) 1.05
Alcohol and drug dependence symptom items as brief screeners for substance use disorders: results from the Clinical Trials Network. J Psychiatr Res (2011) 1.04
Appropriateness of quality indicators for older patients with advanced dementia and poor prognosis. J Am Geriatr Soc (2003) 1.04
Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. Am J Addict (2009) 1.03
Antiangiogenic gene therapy of cancer: recent developments. J Transl Med (2004) 1.03
Depression in long-term care. J Am Med Dir Assoc (2008) 1.03
Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial. Addiction (2010) 1.02
Parenting styles and body mass index trajectories from adolescence to adulthood. Health Psychol (2012) 1.02
The Diversion of Ultram, Ultracet, and generic tramadol HCL. J Addict Dis (2006) 1.02
Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf (2005) 1.01
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? J Surg Oncol (2012) 1.00
Longitudinal association between frequency of substance use and quality of life among adolescents receiving a brief outpatient intervention. Psychol Addict Behav (2009) 1.00
Treatment use and barriers among adolescents with prescription opioid use disorders. Addict Behav (2011) 0.99
Smoking cessation behavior in older adults by race and gender: the role of health problems and psychological distress. Nicotine Tob Res (2009) 0.98
Sociodemographic characteristics of the neighborhood and depressive symptoms in older adults: using multilevel modeling in geriatric psychiatry. Am J Geriatr Psychiatry (2006) 0.98
Relationship of race/ethnicity and blood pressure to change in cognitive function. J Am Geriatr Soc (2002) 0.98
Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Subst Abuse Rehabil (2011) 0.98
Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network. Subst Abuse Rehabil (2010) 0.98
Spirituality and depressive symptoms in a racially diverse US sample of community-dwelling adults. J Nerv Ment Dis (2006) 0.98
Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat (2010) 0.97
Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. Gerontology (2008) 0.97
Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. J Am Geriatr Soc (2011) 0.96
Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults. Am J Geriatr Psychiatry (2009) 0.96
Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J Am Coll Surg (2012) 0.96
Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database. J Psychiatr Res (2011) 0.96
Accuracy of self-reported height and weight in a community-based sample of older African Americans and whites. J Gerontol A Biol Sci Med Sci (2010) 0.96
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend (2009) 0.95
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr (2010) 0.95
Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network. Subst Use Misuse (2011) 0.95
Development of Response Evaluation and Decision (RED) and antisocial behavior in childhood and adolescence. Dev Psychol (2009) 0.95
Does response evaluation and decision (RED) mediate the relation between hostile attributional style and antisocial behavior in adolescence? J Abnorm Child Psychol (2010) 0.95
The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions. Am J Addict (2009) 0.94
Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Subst Abuse Rehabil (2011) 0.94
Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry (2011) 0.94